Monthly Archives: April 2016

Bully Sticks For Dogs Can Help With Separation Anxiety

April 29, 2016 – – Wyldlife Pets, a business in Minneapolis, MN, has announced that their Bully Sticks for dogs can be used to alleviate separation anxiety. The company has indicated that they are committed to providing dogs and dog owners with the best in terms of health and happiness. Separation anxiety is a common thing in dogs, who can get very distressed whenever their human is away. Bully sticks have been observed to be beneficial as a long lasting treat, which helps to redirect the focus of the dog, resulting into a happier and mentally healthier pet. The company offers a range of natural pet chews to help achieve these benefits.

Dan Fernandez from Wyldlife Pets says: “As dog owners, we only want the best for our dogs. There is nothing worse than leaving your dog at home when you know it will be distressed and anxious. With our natural bully sticks, dog owners can provide their four legged friends with something to do, as well as giving them an instant reward for spending time alone. This leaves for both a happier and healthier dog.”

The long lasting treat for dogs that has been created by Wyldlife Pets is a mix pack of bully sticks and tendons. The gourmet treats are both tasty and healthy, meaning dog owners can rest assured they are not causing any harm to their pet. The tendons and bully sticks are 100% natural and do not include any additives, preservatives, chemicals, or hormones. Rather, they are made from the highest quality free range grass fed Angus beef.

“We aimed to create bully sticks that are just what a dog wants and needs,” adds Dan Fernandez. “They smell natural, which is exactly what dogs love as well. The bully sticks are filled with protein, which helps maintain the dental and overall health of your dog, reducing plaque and tartar. The tendons, meanwhile, help to keep gums and teeth strong by gently flossing your dog’s teeth.”

For Wyldlife Pets, a dog is a member of the family. This is why they provide all natural dog treats that are of the highest possible quality. They have also included a 100% satisfaction guarantee, as they are confident that dog owners and dogs alike will love the sticks.

###

Contact Wyldlife Pets:

Dan Fernandez
844-349-WYLD (9953)
info@wyldlifepets.com
7204 W. 27th Street
Suite 220
Minneapolis MN
55426

ReleaseID: 60009569

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Santander Consumer USA Holdings Inc. of Class Action Lawsuit and Upcoming Deadline – SC

NEW YORK, NY / ACCESSWIRE / April 29, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against Santander Consumer USA Holdings Inc. (“Santander” or the “Company”) (NYSE: SC) and certain of its officers. The class action, filed in United States District Court, Northern District of Texas, Dallas Division, and docketed under 16-cv-00919, is on behalf of a class consisting of all persons or entities who purchased Santander securities between February 3, 2015 and March 15, 2016 inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased Santander securities during the Class Period, you have until May 17, 2016 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

Santander is the holding company for Santander Consumer USA Inc., an Illinois corporation, and subsidiaries, a specialized consumer finance company focused on vehicle finance and unsecured consumer lending products.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose: (1) that the Company’s methodology for estimating credit loss allowance on individually acquired retail installment contracts was improper; (2) that, as a result, the Company’s would need to correct its previously issued financial statements; and (3) that, as a result of the foregoing, Defendants’ statements about Santander’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

On February 29, 2016, after the market closed, the Company filed a NT 10-K with the SEC on Form 12b-25 revealing that Santander was unable to timely file its Annual Report on Form 10-K for the Company’s fiscal year ended December 31, 2015 because the Company’s financial statements had not yet been completed. According to the Company, it has an open comment letter from the Division of Corporation Finance of the SEC on the Company’s Form 10-K for the fiscal year ended December 31, 2014 and Form 10-Q for the quarter ended September 30, 2015 with respect to the Company’s credit loss allowance, including the removal of seasonality and the increase in troubled debt restructuring (“TDR”) impairment during the quarter ended September 30, 2015 as well as certain TDR disclosures in both periods. According to the Company, it is still discussing these matters with the SEC and its independent accounting firm and will file the Form 10-K as soon as possible.

On March 15, 2016, the Company revealed that the Company was unable to meet the March 15, 2016, extended filing deadline for its 2015 Annual Report because it was still unable to complete its financial statements. According to the Company, it still has an open comment letter from the Division of Corporation Finance of the SEC on the Company’s Form 10-K for the fiscal year ended December 31, 2014 and Form 10-Q for the quarter ended September 30, 2015 with respect to estimating the Company’s credit loss allowance, including the removal of seasonality and the increase in TDR impairment during the quarter ended September 30, 2015 as well as certain TDR disclosures. According to the Company, as a result of the review, the Company is changing its methodology for estimating credit loss allowance on individually acquired retail installment contracts and will correct prior periods in Item 9B in the Form 10-K. On March 15, 2016, the Company notified the New York Stock Exchange (“NYSE”) that it is not in compliance with Rule 8.01E of the NYSE’s listed company manual as a result of its failure to file the Form 10-K within the extended time period.

On this news, the Company’s shares fell $1.70 per share, or 16%, over two trading sessions to close on March 16, 2016, at $9.00 per share, on high trading volume.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 439412

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amaya, Inc. of Class Action Lawsuit and Upcoming Deadline – AYA

NEW YORK, NY / ACCESSWIRE / April 29, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against Amaya, Inc. (“Amaya” or the “Company”) (NASDAQ: AYA) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-02500, is on behalf of a class consisting of all persons or entities who purchased Amaya securities between June 8, 2015 and March 22, 2016 inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased Amaya securities during the Class Period, you have until May 24, 2016 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

Amaya is a provider of technology-based products and services in the global gaming and interactive entertainment industries. The Company operates through two segments, Real-Money Online Poker, and Real-Money Online Casino and Sportsbook.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose: (1) that the Company’s Chief Executive Officer (“CEO”) was engaged in an insider trading scheme that involved influencing the market price of the Company’s securities and communicating privileged information to third parties; (2) the Company lacked adequate internal controls; and (3) that, as a result of the foregoing, Defendants’ statements about Amaya’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

On March 23, 2016, news outlets reported that Amaya’s CEO, David Baazov, was charged with insider trading by Quebec securities regulators. Bloomberg Business reported that the charges included “allegations of ‘aiding with trades while in possession of privileged information,’ influencing or attempting to influence the market price of securities of Amaya, and communicating privileged information.”

On this news, Amaya’s stock fell $3.07 per share, or more than 21%, to close at $11.18 per share on March 23, 2016, on unusually heavy trading volume.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 439415

2016 Pipeline of Liver Cirrhosis Market Covering 14 Companies

ReportsnReports adds Liver Cirrhosis Pipeline Market research to its database.

2016 Pipeline of Liver Cirrhosis Market Covering 14 Companies

Pune, India – April 29, 2016 /MarketersMedia/

Liver Cirrhosis Pipeline Market Companies Involved in Therapeutics Development are Conatus Pharmaceuticals Inc., Digna Biotech, S.L., Galectin Therapeutics, Inc., Gilead Sciences, Inc., GNI Group Ltd., Human Stem Cells Institute, INVENT Pharmaceuticals, Inc., Nimbus Therapeutics, LLC, Pacific Therapeutics Ltd., ,PharmaIN Corporation Pharmicell Co., Ltd., S-Evans Biosciences, Inc., Stelic Institute & Co., Inc. and Stempeutics Research Private Limited.

The report provides comprehensive information on the therapeutics under development for Liver Cirrhosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Liver Cirrhosis and features dormant and discontinued projects.

Get discount on this research report at http://www.reportsnreports.com/contacts/Discount.aspx?name=538054

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

• The report provides a snapshot of the global therapeutic landscape of Liver Cirrhosis
• The report reviews pipeline therapeutics for Liver Cirrhosis by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved Liver Cirrhosis therapeutics and enlists all their major and minor projects
• The report assesses Liver Cirrhosis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news related to pipeline therapeutics for Liver Cirrhosis

Complete research report of 102 pages with TOC is available at http://www.reportsnreports.com/reports/538054-liver-cirrhosis-pipeline-review-h1-2016.html

Reasons to buy

• Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of therapeutics under development for Liver Cirrhosis
• Identify potential new clients or partners in the target demographic
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
• Devise corrective measures for pipeline projects by understanding Liver Cirrhosis pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

For more information about us, please visit http://www.reportsnreports.com/

Contact Info:
Name: Ritesh Tiwari
Organization: ReportsandReports
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
Phone: +1888 391 54 41

Source: http://marketersmedia.com/2016-pipeline-of-liver-cirrhosis-market-covering-14-companies/112906

Release ID: 112906

Altavoz Announces Name & Ticker Symbol Change And Satisfaction of Key Condition

WASHINGTON, DC / ACCESSWIRE / April 29, 2016 / Altavoz Entertainment, Inc. “AVOZ,” (OTCPINK: AVOZ), On March 20th FINRA approval of our change of company name and stock ticker symbol Effective March 20th, the Company’s common shares will commence trading on the OTC Bulletin Board pinks, under the trading symbol “AVOZ” (OTCPINK: AVOZ), and The previous name was Max Media Group, Inc. and trading symbol was “MXMI”(OTCPINK: MXMI)

“This name and ticker symbol change reflects the transfer of control and direction to an Artists Owned Public company and Future of Entertainment Today which the AvozFamily looks forward to presenting to the markets,” Nelson Jacobsen, CEO.

As Previously announced, on September 25,
2015 the majority control of Max Media Group, Inc was transferred to Altavoz and as part of the conditions of the transfer of choosing a new name and ticker symbol.

About Altavoz Entertainment, Inc.

Altavoz is an independent, full-service entertainment distributor offering a wide range of physical and digital distribution, marketing and payment solutions. Altavoz is widely known for being
distributor of record for the highly acclaimed “Goldenheart” project from Dawn Richard. To that end, Altavoz ensures artists and producers have access to a unique array of traditional and out-of-the-box distribution channels and are creatively promoted so they can build their presence, make their mark, and earn a living – all with a social conscience via our Help Earth Foundation. Altavoz is a subsidiary of Altavoz Entertainment, Inc. (OTC – AVOZ ) visit http://altavoz.com.

COMPANY STATEMENT

Forward-Looking Statement

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements, as described in our reports filed with the Securities and Exchange Commission which are available for review at www.sec.gov, to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Nelson Jacobsen, CEO

SOURCE: Altavoz Entertainment, Inc.

ReleaseID: 439421

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in TerraForm Power Inc. of Class Action Lawsuit and Upcoming Deadline – TERP

NEW YORK, NY / ACCESSWIRE / April 29, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against TerraForm Power Inc. (“TerraForm” or the “Company”) (NASDAQ: TERP) and certain of its officers. The class action, filed in United States District Court, District of Maryland, and docketed under 16-cv-00981, is on behalf of a class consisting of all persons or entities who purchased TerraForm securities between May 7, 2015 and March 15, 2016 inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased TerraForm securities during the Class Period, you have until June 3, 2016 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

TerraForm owns and operates solar and wind generation assets serving utility, commercial, and residential customers.

TerraForm was founded in 2014. The Company was formerly known as SunEdison Yieldco, Inc. and changed its name to TerraForm Power, Inc. in May 2014.

TerraForm’s controlling shareholder is SunEdison, Inc. (“SunEdison”), and there is significant overlap between the management of TerraForm and SunEdison and SunEdison’s other affiliates: Brian Wuebbels (“Wuebbels”), TerraForm’s former Chief Executive Officer (“CEO”), has served as Chief Financial Officer (“CFO”) and Executive Vice President of SunEdison since May 2012 and as SunEdison’s Chief Administrative Officer since December 2014; Rebecca Cranna (“Cranna”), TerraForm’s CFO, has served as SunEdison’s Senior Vice President and CFO of Global Asset Management since 2014; and defendant Carlos Domenech Zornoza (“Domenech”), TerraForm’s former CEO, served as Executive Vice President of SunEdison from November 2009 to January 2014, and has held management positions at other SunEdison affiliates, including SunEdison Capital, LLC and SunEdison LLC.

The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) TerraForm’s Management Services Agreement with SunEdison exposed TerraForm to risks associated with SunEdison’s internal financial controls and any deficiencies therein; (ii) consequently, TerraForm lacked effective internal financial controls; and (iii) as a result of the foregoing, TerraForm’s public statements were materially false and misleading at all relevant times.

On February 29, 2016, SunEdison announced that it was delaying the filing of its fiscal year 2015 Form 10-K with the SEC, citing “(1) the need to complete all tasks and steps necessary to finalize the annual financial statements and the other disclosures required to be included in that filing, and (2) ongoing inquiries and investigations by the Audit Committee . . . relating to allegations concerning the accuracy of SunEdison’s anticipated financial position.” SunEdison stated that it expected to file its Form 10-K by March 15, 2016.

On February 29, 2016, TerraForm also announced that it was delaying the filing of its fiscal year 2015 Form 10-K with the SEC and also expected to file the Form 10-K by March 15, 2016. TerraForm cited only “the need to complete all steps and tasks necessary to finalize the Company’s annual financial statements and other disclosures required to be in the filing.”

On March 16, 2016, SunEdison announced a further delay in the filing of its Form 10-K beyond the extended due date of March 15, 2016, after “the identification by management of material weaknesses in its internal controls over financial reporting.”

On March 16, 2016, TerraForm also announced a further delay in the filing of its Form 10-K beyond the extended due date of March 15, 2016, after identifying material weaknesses in its internal controls over financial reporting.

On this news, TerraForm stock fell $0.83, or 7.87%, to close at $9.72 on March 16, 2016.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 439418

Transfer Switch Market to Hit a CAGR of 6.6% to 2020 Led by Automatic Transfer Switch Segment

The transfer switch market is expected to reach $1,470.9 Million by 2020, at a CAGR of 6.6% from 2015 to 2020 led by automatic transfer switch segment and propelled by industrial applications, infrastructural developments, need for uninterrupted and reliable power.

Transfer Switch Market to Hit a CAGR of 6.6% to 2020 Led by Automatic Transfer Switch Segment

Pune, India – April 29, 2016 /MarketersMedia/

This report estimates the transfer switch market, in terms of value. The market has been segmented into (type, transition mode, ampere rating, application), and regions (North America, Europe, Asia-Pacific, and RoW). The automatic transfer switch is further segmented into static, contactor-based and circuit breaker based transfer switch.

Complete report on global transfer switch market spread across 214 pages, profiling 15 companies and supported with 67 tables and 45 figures is now available at http://www.reportsnreports.com/reports/404473-transfer-switch-market-by-type-automatic-manual-transition-mode-open-closed-delayed-soft-load-ampere-rating-0-300a-301a-16ka-16ka-4ka-applications-industrial-commercial-residential-and-region-global-trends-and-forecasts-to-2020.html .

The transfer switch market is expected to reach $1,470.9 Million by 2020, at a CAGR of 6.6% from 2015 to 2020. Asia-Pacific accounts the largest market share of transfer switch due to the growing trend in the industrial and commercial sector especially in countries such as China and India. However, most of the countries in this region are still developing and lacks proper power distribution infrastructure. This leads to outages, blackouts, brownouts, and power surges. This is driving the transfer switch market in this region and is expected to be the leading market by 2020. China is investing a lot for the expansion of its power sector and is also one of the leading markets for the sales of generators and electrical equipment.

North America and Europe stood at the second and third position in the global transfer switch, respectively, in 2014. U.S., Germany, U.K. are the major countries in two regions and held a significant share in the global market. France, Mexico, and Canada are expected to be the fastest growing countries with high growth rate in next five years period.

Power back-up is one prime requirement for the various industries such as data centers, infrastructural development, and commercial applications. Unreliable grid operations and whether conditions are forcing to install power back-up or alternative source which drives the demand for transfer switch across the globe.

Various secondary sources such as encyclopedia, directories, and databases have been used to identify and collect information useful for this extensive commercial study of global transfer switch market. The primary sources include experts from industry and suppliers have been interviewed to obtain and verify critical information as well as to assess the future prospects of the transfer switch market.

The transfer switch market in Asia-Pacific accounted for the largest share of around 40% in 2014. China is the largest market in this region and is expected to continue its dominance in the transfer switch industry.

The market is led by players such as ABB Ltd. (Switzerland), General Electric (U.S.), Cummins Inc. (U.S.), Emerson Electric Company (U.S.), Eaton Corporation PLC. (Ireland), Kohler Power (U.S.), Marathon Thomson Power System (Canada), and Generac Power Systems (U.S.). Ask for discount before order a copy of Transfer Switch Market by Type (Automatic & Manual), Transition Mode (Open, Closed, Delayed, & Soft Load), Ampere Rating (0-300A, 301A-1.6kA, 1.6kA-4kA), Applications (Industrial, Commercial, & Residential) and Region – Global Trends and Forecasts to 2020 research report at http://www.reportsnreports.com/contacts/discount.aspx?name=404473 .

The transfer switch market is segmented on the basis of type, application, transition mode, ampere rating, and region. On the basis of type, the market is segmented into automatic and manual. In terms of transition mode, the market is segmented into open, closed, delayed, soft load transition. The market based on ampere rating covers 0-300A, 301-1600A, and 1600A-4000A. The market is further segmented on the basis of regions such as North America, Asia-Pacific, Europe, and RoW.

On a related note, another research on Pad-Mounted Switchgear Market Global Trends & Forecast to 2020 says, the market is expected to reach a value of USD 6.3billion by 2020, at a CAGR of 9.1% during 2015-2020. Increasing T&S infrastructure investments along with the rising trend towards placing electrical lines underground is driving the market. Air insulated pad-mounted switchgear dominates the global market. Asia-Pacific is the fastest growing market for pad-mounted switchgear. Companies like Eaton Corporation plc (Ireland), G&W Electric (U.S.), Federal Pacific (U.S.), Hubbel Incorporated (U.S.), and S&C Electric Company (U.S.) have been profiled in this 128 pages research report available at http://www.reportsnreports.com/reports/433262-pad-mounted-switchgear-market-by-type-air-insulated-gas-insulated-others-by-voltage-rating-0-15kv-16-25kv-above-25kv-by-application-industrial-commercial-residential-by-region-global-trends-forecast-to-2020.html .

About Us:

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

For more information about us, please visit http://www.rnrmarketresearch.com

Contact Info:
Name: Ritesh Tiwari
Organization: ReportsnReports
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar
Phone: +1-888-391-5441

Source: http://marketersmedia.com/transfer-switch-market-to-hit-a-cagr-of-6-6-to-2020-led-by-automatic-transfer-switch-segment/112726

Release ID: 112726

Zhonghai Wanyue Chairman Requests More Time to Complete Transfer of Funds to Peak

MONTREAL, QC / ACCESSWIRE / April 29, 2016 / Peak Positioning Technologies Inc. (CSE: PKK) (OTC Pink: PKKFF) (“Peak” or the “Company”) today announced that following a conference call earlier today between Zhonghai Wanyue Group Chairman, Mr. Jiang Wang, and the Company’s management, that Mr. Wang has officially asked to be given until May 15 to send to Peak the balance of $3.44M remaining on their original $3.98M strategic investment partnership agreement.

Mr. Wang explained that he will need more time than originally anticipated to cash out and withdraw the necessary funds from his account due to recently passed regulations affecting certain sectors of the Chinese financial services industry. “Since the new regulations, certain transactions that typically were completed within 24 to 48 hours, for instance, having a cheque cleared, can now take up to two weeks to complete”, commented Mr. Wang. “I realize that there are a number anxious Peak shareholders who have been waiting for quite a while now for this transaction to close, some of whom I met during my visit to Montreal a couple of weeks ago. I’d like to apologise to these shareholders and would like to re-assure them that it’s simply a matter of time, and as simple as cashing a cheque, before the funds to be sent to Peak are made available for the transfer to be completed and the transaction closed,” concluded Mr. Wang.

The time delay to complete the transaction requested by Mr. Wang also takes into consideration the Chinese Labour Day holiday, which this year takes place from April 30 to May 4.

About Peak Positioning Technologies Inc.:

Peak Positioning Technologies Inc. is an IT portfolio management company whose mission is to assemble, finance and manage a portfolio of high-growth-potential companies and assets in some of the fastest growing tech sectors in China, including Fintech, e-commerce and cloud-computing. Peak provides its shareholders with exceptional growth potential by giving them access to the fastest growing sectors of the world’s fastest growing economy. For more information: http://www.peakpositioning.com

Contact information:

Cathy Hume
CEO
CHF Investor Relations
Phone: 416-868-1079 ext.: 231
Email: cathy@chfir.com

Or

Carl Desjardins
Managing Partner
Paradox Public Relations Inc.
Phone: 514-341-0408
Email: carldesjardins@paradox-pr.ca

Or

Johnson Joseph
President and CEO
Peak Positioning Technologies Inc.
Phone: 514-340-7775 ext.: 501
Email: investors@peakpositioning.com

SOURCE: Peak Positioning Technologies Inc.

ReleaseID: 439420

Earth Alive Reports Fourth Quarter and Year End Results for 2015

MONTREAL, QC / ACCESSWIRE / April 29, 2016 / Earth Alive Clean Technologies Inc. (CSE: EAC) (“Earth Alive” or the “Corporation”), a leading developer and manufacturer of state-of-the-art microbial technology-based products for agriculture and dust control, today reported its financial results and operational highlights for its fourth quarter and year ended December 31, 2015.

Highlights from FY 2015:

– Revenues of $1,356,540 for the year, a 382% year over year increase
– Agriculture revenues of $469,282, a 630% year over year increase
– Dust revenues of $887,258 for the year, a 316% year over year increase
– Signed an exclusive three-year agreement with Brenntag Latin America for the production and sales of its patent-pending EA1 dust suppressant product

“This past year, Earth Alive’s microbial technologies began disrupting the agriculture and dust suppression industries,” stated David Gilmour, CEO of Earth Alive. “2015 was filled with watershed moments and I am extremely pleased that we delivered considerable traction for our Corporation on multiple fronts; we moved beyond the R&D stage and focused on setting the stage for the planned international commercialization of Earth Alive’s proprietary product portfolio. The Corporation was successful at following its business development plan and at realizing many milestones, namely the exclusive distribution agreement reached with Brenntag Latin America for our EA1 dust suppression product, quickly followed by a similar agreement with Brenntag for our Soil Activator™ biofertilizer. We continue to work hard to strengthen our partnership with Brenntag to leverage their distribution network for both our Agriculture and Dust Suppression Business Units. The Earth Alive team is continuing to prove that business objectives and environmental sustainability can make great partners.”

Mr. Gilmour added, “Reaping the rewards of our new international distribution agreements is a process that takes time and patience to leverage, and we remain totally focussed on executing this business plan. We are more than ever confident that we are on the right path to bringing significant value for our shareholders. “

Financial Highlights for the Fourth Quarter and Year Ended December 31:

    Three months ended     Year ended  
    December 31,     December 31,  
In Canadian Dollars   2015     2014     2015     2014  
Revenue   464,966     60,226     1,356,540     355,583  
Gross Margin   252,712     (12,319)   596,047     136,604  
%   54.4%     -20.5%     43.9%     38.4%  
Operating Expenses   865,614     516,020     2,461,641     2,027,377  
Financial (Income) Expenses   36,596     (10,818)   140,944     992,378  
Net Loss   (628,271)     (517,521)   (1,882,797)   (2,883,151)

About Earth Alive Clean Technologies:

Earth Alive aims to be a key player in world markets of environmentally sustainable industrial solutions. The company works with the latest innovations in microbial technology to formulate and patent innovative products that can tackle the most difficult industrial challenges, once only reserved to environmentally harmful chemicals and additives. The company is focused on environmental sustainability in 1) dust control for the mining industry, and 2) the agriculture industry.

For additional company information, please visit SEDAR at www.sedar.com and www.earthalivect.com.

The CSE has neither approved nor disapproved the contents of this press release. The CSE does not accept responsibility for the adequacy or accuracy of this release.

Forward Looking Information

Except for statements of historical fact, this news release contains certain forward-looking statements within the meaning of applicable securities law. Forward-looking statements are frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” occur. Although Earth Alive believes that the expectations reflected in the forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information, whether as a result of new information, future events or otherwise.

Earth Alive Clean Technologies Inc.
1001, Lenoir Street, Suite B-338
Montreal (Qc) Canada
H4C 2Z6
T.(438) 333-1680

For media information and interview requests, please contact:

Mr. David Gilmour
(e) dgilmour@earthalivect.com
(p) 514-814-2899

For investor relations, please contact:

Mr. Frédérick Chabot
(e) frederick@contactfinancial.com
(p) 438-863-7071

SOURCE: Earth Alive Clean Technologies Inc.

ReleaseID: 439419

Pipeline of Sinusitis Market 2016 Covering 8 Companies

ReportsnReports adds Sinusitis Pipeline Market research to its database.

Pipeline of Sinusitis Market 2016 Covering 8 Companies

Pune, India – April 29, 2016 /MarketersMedia/

Sinusitis Pipeline Market Companies Involved in Therapeutics Development are Amgen Inc., F. Hoffmann-La Roche Ltd., Knopp Biosciences LLC, Merck & Co., Inc., Oticpharma Ltd, Paratek Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. and Therabron Therapeutics, Inc.

The report provides comprehensive information on the therapeutics under development for Sinusitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Sinusitis and features dormant and discontinued projects.

Get discount on this research report at http://www.reportsnreports.com/contacts/Discount.aspx?name=538062

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

• The report provides a snapshot of the global therapeutic landscape of Sinusitis
• The report reviews pipeline therapeutics for Sinusitis by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved Sinusitis therapeutics and enlists all their major and minor projects
• The report assesses Sinusitis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news related to pipeline therapeutics for Sinusitis

Complete research report of 80 pages with TOC is available at http://www.reportsnreports.com/reports/538062-sinusitis-pipeline-review-h1-2016.html

Reasons to buy

• Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of therapeutics under development for Sinusitis
• Identify potential new clients or partners in the target demographic
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
• Devise corrective measures for pipeline projects by understanding Sinusitis pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

For more information about us, please visit http://www.reportsnreports.com/

Contact Info:
Name: Ritesh Tiwari
Organization: ReportsandReports
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
Phone: +1888 391 54 41

Source: http://marketersmedia.com/pipeline-of-sinusitis-market-2016-covering-8-companies/112904

Release ID: 112904